Search

Your search keyword '"Wever‐Pinzon, Omar"' showing total 418 results

Search Constraints

Start Over You searched for: Author "Wever‐Pinzon, Omar" Remove constraint Author: "Wever‐Pinzon, Omar"
418 results on '"Wever‐Pinzon, Omar"'

Search Results

2. Cardiac Reverse Remodeling Mediated by HeartMate 3 Left Ventricular Assist Device: Comparison to Older Generation Devices

3. Safety and Efficacy of Metabolic Modulation With Ninerafaxstat in Patients With Nonobstructive Hypertrophic Cardiomyopathy

4. Health-related Quality of Life as a predictor of Heart Failure Admission and Death in Patients with Amyloidosis PC41 (#284)

5. Bridge‐to‐transplant temporary mechanical circulatory support and risk of allosensitization

8. Impact of Diabetes and Glycemia on Cardiac Improvement and Adverse Events Following Mechanical Circulatory Support.

9. Distinct Transcriptomic and Proteomic Profile Specifies Patients Who Have Heart Failure With Potential of Myocardial Recovery on Mechanical Unloading and Circulatory Support

10. Complication Rates Of Temporary Mechanical Circulatory Support In Patients With Cardiogenic Shock

11. Cumulative long-term efficacy and safety of mavacamten treatment in nonobstructive hypertrophic cardiomyopathy: updated interim analysis from the MAVERICK cohort of the MAVA-long-term extension (LTE) study up to 120 weeks

12. Health-related Quality Of Life As A Predictor Of Heart Failure Admission And Death In Patients With Amyloidosis

13. Low Seroprevalence of Neutralizing Antibodies to Adeno-Associated Virus Serotype 9 (AAV9) in Preparation for MyPeak-1, the First-in-Human Study of TN-201, an Investigational AAV9-Mediated Gene Therapy for Individuals with MYBPC3-Associated Hypertrophic Cardiomyopathy (HCM)

14. Abstract 11629: Multicenter Development and Validation of a Machine Learning Risk Model to Predict Right Ventricular Failure Following Mechanical Circulatory Support: The STOP-RVF Score

15. Abstract 11588: Multicenter Development and Validation of a Machine Learning Model to Predict Myocardial Recovery During LVAD Support: The UCAR Score

19. Machine Learning Multicenter Risk Model to Predict Right Ventricular Failure After Mechanical Circulatory Support: The STOP-RVF Score.

20. Machine Learning Identification Of Transcriptomics And Clinical Characteristics Associated With Myocardial Recovery In Heart Failure Patients Undergoing Mechanical Circulatory Support

21. The Role of Nonglycolytic Glucose Metabolism in Myocardial Recovery Upon Mechanical Unloading and Circulatory Support in Chronic Heart Failure

23. HEALTH RELATED QUALITY OF LIFE AS PREDICTOR OF OUTCOMES IN HEART FAILURE WITH PRESERVED EJECTION FRACTION

24. IMPAIRED LIVER FUNCTION IS ASSOCIATED WITH HYPOTENSION AND ELEVATED RIGHT ATRIAL PRESSURE BUT NOT DEPRESSED CARDIAC INDEX IN CHRONIC HEART FAILURE

25. Myocardial Structural and Functional Response After Long-Term Mechanical Unloading With Continuous Flow Left Ventricular Assist Device: Axial Versus Centrifugal Flow

33. Supportive Cardiac Magnetic Resonance Imaging (CMR) Features for Differentiating Hypertrophic Cardiomyopathy and Cardiac Amyloidosis.

34. A novel donor-derived cell-free DNA assay for the detection of acute rejection in heart transplantation

35. Microvascular Loss and Diastolic Dysfunction in Severe Symptomatic Cardiac Allograft Vasculopathy

38. Clinical and histopathological effects of heart failure drug therapy in advanced heart failure patients on chronic mechanical circulatory support

40. A novel donor-derived cell-free DNA assay for the detection of acute rejection in heart transplantation.

42. Right Heart Failure Following Left Ventricular Device Implantation: Natural History, Risk Factors, and Outcomes: An Analysis of the STS INTERMACS Database

43. Predicting Cardiac Structural And Functional Improvement On Left Ventricular Assist Device Support: The Externally Validated UCAR Score

44. Twelfth Interagency Registry for Mechanically Assisted Circulatory Support Report: Readmissions after LVAD

47. Twelfth Interagency Registry for Mechanically Assisted Circulatory Support Report: Readmissions After Left Ventricular Assist Device

48. Fatal Allograft Rejection and Cardiac Allograft Vasculopathy After Treatment With Pembrolizumab for Metastatic Melanoma in a Heart Transplant Recipient: A Case Report

50. Abstract 9685: Long-Term Efficacy and Safety of Mavacamten in Patients with Non-Obstructive Hypertrophic Cardiomyopathy: Interim Results from the MAVERICK-LTE Cohort of the MAVA-LTE Study

Catalog

Books, media, physical & digital resources